Lung nodules are commonly found on chest CT scans. Nodules are usually benign but can be cancerous. It is important to identify lung nodules and monitor them over time to ensure the earliest possible cancer diagnosis and treatment.
Lung nodules can lead to lung cancer which is the leading cause of cancer death in the U.S.
The Lung Nodule Registry Program at National Jewish Health is the first of its kind in the country. We created a database of patients with identified lung nodules and a way to communicate with them and their doctors when follow-up CT scans are needed. This infrastructure is needed to keep a watchful eye on lung nodules for early cancer detection.
The program includes:
Use of structured reports by radiologists to report nodules and recommend follow-up
Database to track the CT scan findings and follow-up CT scans
Communication plan to encourage patients to return for follow-up CT scanning
Sending reminder communications to patients who need follow-up scans
Communicating to physicians regarding their patients’ follow-up CT scanning based on best evidence for high-risk and non-high-risk patients
Sending reminder communications to patients who are past due for follow-up CT scans
Sending CD copies of past CT scans to patients who may have follow-up elsewhere
For more than 100 years, National Jewish Health has been committed to finding new treatments and cures for diseases. Search our clinical trials.
Reasons to Choose National Jewish Health
The leading respiratory hospital in the nation and the only one
devoted fully to the treatment of respiratory and related
Ranked #1 or #2 in Pulmonology by
U.S. News & World Report for 26 consecutive years
Ranked in the top 5% of hospitals in the nation by HCAHPS
Physicians consistently recognized among the best in the nation by
multiple services, including Best Doctors in America and Castle
Among the top 6% of organizations funded for research by the NIH,
providing patients access to hundreds of active clinical trials
124-year history of focus on care, research and education serving
patients from around the world with lung, heart, immune and